| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,679 |
2,414 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,546 |
2,271 |
$77K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,507 |
1,022 |
$58K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
985 |
680 |
$55K |
| 11750 |
|
435 |
276 |
$33K |
| 17110 |
|
538 |
269 |
$14K |
| 11721 |
|
1,511 |
1,036 |
$9K |
| 29540 |
|
1,075 |
559 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
387 |
256 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
99 |
93 |
$4K |
| 93922 |
|
288 |
234 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
123 |
64 |
$2K |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
19 |
13 |
$2K |
| 29581 |
|
88 |
64 |
$1K |
| 20551 |
|
88 |
50 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
623 |
335 |
$62.98 |
| G0246 |
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education |
21 |
18 |
$0.00 |
| 99024 |
|
186 |
89 |
$0.00 |
| 3044F |
|
49 |
34 |
$0.00 |